Last reviewed · How we verify
Kalcipos-D
Kalcipos-D combines calcipotriol (a vitamin D analog) with calcium carbonate to regulate calcium and phosphate metabolism and promote bone mineralization.
Kalcipos-D combines calcipotriol (a vitamin D analog) with calcium carbonate to regulate calcium and phosphate metabolism and promote bone mineralization. Used for Hypocalcemia and vitamin D deficiency, Secondary hyperparathyroidism, Osteoporosis prevention and treatment.
At a glance
| Generic name | Kalcipos-D |
|---|---|
| Sponsor | Takeda |
| Drug class | Vitamin D analog with calcium supplement |
| Target | Vitamin D receptor (VDR) |
| Modality | Small molecule |
| Therapeutic area | Endocrinology / Bone Metabolism |
| Phase | FDA-approved |
Mechanism of action
Calcipotriol is a synthetic vitamin D3 analog that binds to vitamin D receptors to enhance intestinal calcium absorption and regulate serum calcium and phosphate levels. The addition of calcium carbonate provides supplemental elemental calcium. Together, these components work to correct hypocalcemia and support bone health in patients with vitamin D deficiency or impaired calcium metabolism.
Approved indications
- Hypocalcemia and vitamin D deficiency
- Secondary hyperparathyroidism
- Osteoporosis prevention and treatment
Common side effects
- Hypercalcemia
- Hyperphosphatemia
- Nausea
- Constipation
Key clinical trials
- Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation. (PHASE4)
- Vitamin D and Physical Performance Before and After Intervention and Birth Outcome in Pregnant Somali and Swedish Women (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Kalcipos-D CI brief — competitive landscape report
- Kalcipos-D updates RSS · CI watch RSS
- Takeda portfolio CI